Drugs / HEC30654AcOH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03655873 | Nov 2018 → Dec 2019 | — | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HEC30654AcOH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03655873 ↗ |
| Action | Inhibit | “selective 5-ht6 receptor antagonist” NCT03655873 ↗ |